Laronde

Flagship Pioneering has unveiled its latest new biotech company, called Quotient, with an ambitious goal of tapping into new insights in somatic genomics, and the trillions of DNA changes each person

Venture capital mega-rounds of $100m or more – like the $245m series A round that Aiolos Bio Inc. announced on 24 October – have played a big part in surging quarterly and annual totals of biopharma

Arbor Biotechnologies , Acrivon Therapeutics Inc. and bit.bio are the newest members of the biopharma venture capital mega-round club after the companies announced series B rounds totaling $215m, $100

The IPO market slowed down in August but it looks like first-time offerings will regain their momentum in September, still on track for 2021 to be the most active year since the dot-com boom year of 2